Cinven, a private equity group, announced today that it is to buy Amdipharm for 367 million pounds. Amdipharm is a family-owned niche pharmaceutical company. The intention is to merge Amdipharm ...

Then $75 per month. Complete digital access to quality FT journalism on any device. Cancel anytime during your trial. Complete digital access to quality FT journalism with expert analysis from ...

The group, owned by private equity firm Cinven Ltd., will access over $150 million of extra liquidity for operations with the deal, according to people familiar with the matter, who asked not to ...